The largest conference dedicated to the gynecologic cancer community. Free and open to all.
OCRA’s International Gynecologic Cancer Conference is the largest online event dedicated to education, support, and connection for those impacted by ovarian, endometrial, cervical, and other gynecologic cancers—bringing the experts to you, wherever you are.
This year’s conference offers dedicated programming for ovarian, endometrial, cervical, and rare gynecologic cancers, so you can spend your time on the updates and conversations that speak directly to your experience. And for the first time, each of these diagnoses has its own individual Ask the Experts session.
Join us to learn from the top clinicians, hear what’s on the horizon in clinical trials, and connect with a community that understands.
Whether you’re newly diagnosed, in treatment, off treatment, or supporting someone you love, there’s a place for you here.
Agenda is current as of August 26, 2026 and is subject to change. All times are listed in EDT (Eastern Daylight Time).
Welcome and Opening Remarks
Sponsored by Lilly
(11:00 am – 12:00 pm)
-Audra Moran, OCRA’s President & CEO
Navigating Survivorship
Sponsored by Lilly
(12:00 pm – 1:00 pm)
-Jill Aldredge, MD
Ask the Experts Part 1 (Dedicated Sessions)
(1:00 pm – 1:45 pm)
In these four dedicated sessions, our live panels of experts answer your important questions about research, treatment, and survivorship specific to diagnosis of ovarian, endometrial, cervical, or rare gynecologic cancer.
Ovarian Cancer
Sponsored by AbbVie
-Kevin Elias, MD
-Ursula Matalonis, MD
-Oladapo Yeku, MD, PhD, FACP, FASCO
Endometrial Cancer
Sponsored by Genmab
-Vickie Bae-Jump, MD, PhD
-Stephanie Gaillard, MD, PhD
-Tarik Silk, MD
Cervical Cancer
Sponsored by Merck
-Steven Holloway, MD
-Leslie Randall, MD
-Ana Tergas, MD
Rare Gynecologic Cancers
Sponsored by PMV Pharmaceuticals
-Jubilee Brown, MD
-Amanda Fader, MD
-John Farley, MD
Ask the Experts Part 2 (Dedicated Sessions)
(1:50pm-2:30pm)
Ovarian Cancer
Sponsored by Zentalis
-Kevin Elias, MD
-Ursula Matalonis, MD
-Oladapo Yeku, MD, PhD, FACP, FASCO
Endometrial Cancer
Sponsored by Natera Oncology
-Vickie Bae-Jump, MD, PhD
-Stephanie Gaillard, MD, PhD
-Tarik Silk, MD
Cervical Cancer
Sponsored by Pfizer
-Steven Holloway, MD
-Leslie Randall, MD
-Ana Tergas, MD
Rare Gynecologic Cancers
Sponsored by Verastem
-Jubilee Brown, MD
-Amanda Fader, MD
-John Farley, MD
The Role of Lifestyle and Caregivers in Your Cancer Care – Moving, Eating, and Caring Well
Sponsored by Eisai
(2:30 pm – 3:30 pm)
-Shannon Armbruster, MD, MPH
-Abigail Zamarano, MD, MPHS
Talking Clinical Trials (Dedicated Sessions)
(3:30 pm – 4:00 pm and 4:00-4:30pm)
Easing the Burden: Symptom Management for Gynecologic Cancer
Sponsored by AstraZeneca
(4:30 pm – 5:30 pm)
-Lisa Landrum, MD, PhD
Community Connections
Sponsored by AstraZeneca
(5:30 pm – 6:30 pm)
-OCRA Support and Education Team
Reflections
Sponsored by Lilly
(10:00 am – 11:00 am)
-OCRA Support Team
Dedicated Sessions
(11:00 am – 12:00 pm)
Ovarian Cancer: Managing Ovarian Cancer Recurrence
Sponsored by Corcept Therapeutics
-Sarah Adams, MD
Endometrial Cancer: Managing Endometrial Cancer Recurrence
Sponsored by AbbVie
-M. Yvette Williams-Brown, M.D., MMSc
Cervical Cancer: Radiation Therapy Updates and Advances
Sponsored by GSK
-Lillie L. Lin, MD
Rare Gynecologic Cancers: LGSOC and Borderline Ovarian Tumor Updates
Sponsored by Verastem
-Beryl Manning-Geist, MD, FACOB
From Bench to Bedside Panel: How Do We Go From Research to Treatment?
Sponsored by GRAIL
(12:00 pm – 1:00 pm)
This session will discuss the process of translating scientific discoveries into new cancer treatments, how findings from laboratory research are used to develop new interventions, and how these are tested, evaluated, and then integrated into clinical practice.
-Alessia Baccarini, PhD
-Roisin O’Cearbhaill, MD
-Madeline Merrill, MSN, AGNP-BC
-Kay Ertmanis
-Dmitriy Zamarin, MD, PhD
FDA Listening Session
Sponsored by Regeneron
(1:00 pm – 2:00 pm)
This special session is an opportunity to ask questions about the FDA’s role in drug development and approval, learn how patient perspectives inform decision-making, and help shape the future of gynecologic cancer care. The panel will answer questions submitted in advance as well as live questions from attendees.
-Michelle Olson, DO
-Christy Osgood, MD
-Gwynn Ison, MD
-Sakar Wahby, PharmD
Talking Clinical Trials
(2:00 pm – 2:30 pm and 2:30 pm – 3:00 pm)
Talking through Tough Moments: Navigating Difficult Conversations
Sponsored by GSK
(3:00 pm – 4:00 pm)
-Rachel Montague, FNP-C, PMHNP-BC, ACHPN
A Conversation With Tig Notaro
(4:00 pm – 4:30 pm)
Please note, this session will not be available for replay.
Closing Remarks
Sponsored by Genelux
Community Connections
Sponsored by Lilly
(5:30 pm – 6:30 pm)
-OCRA Support Team
A Conversation With Tig Notaro
We are honored and excited to welcome comedian, actor, and filmmaker Tig Notaro to speak at OCRA’s International Gynecologic Cancer Conference®. In this special conversation to close our Conference, Tig will share her perspective as a cancer survivor, lessons from the film, and the many ways we can learn to live beyond a cancer diagnosis. This conversation will only be available to watch live at the Conference, so you don’t want to miss it.
The Role of Lifestyle and Caregivers in Your Cancer Care: Moving, Eating, and Caring Well
Discover how nutrition, physical activity, and caregivers can support well-being during and after treatment for both patients and loved ones. Bring your questions for a live Q&A with the experts.
FDA Listening Session
Join leaders from the U.S. Food and Drug Administration (FDA) for an interactive conversation about living with gynecologic cancer. Share your experiences with diagnosis, biomarker and genetic testing, treatment decisions, side effects, quality of life, and the challenges you’ve faced along the way.
From Bench to Bedside: How Research Becomes Treatment
Gain a better understanding of how scientific discoveries move from the laboratory to clinical trials and ultimately become standard treatments. Experts will also discuss the patient treatment experience and the important role clinical trials play in advancing care.
Ask the Experts: Ovarian, Endometrial, Cervical, and Rare Gynecologic Cancers
Choose from four diagnosis-specific expert panels offering in-depth discussions on treatment options, research advances, biomarker testing, survivorship, side effect management, supportive care, and more. Submit your questions in advance or ask them live during the sessions.
Navigating Survivorship
Explore practical strategies for living well beyond diagnosis, with guidance on emotional well-being, physical health, sexual health, and finding the support you need throughout survivorship.
And much more, including dozens of educational sessions, inspiring stories, interactive discussions, and opportunities to connect with a compassionate community that truly understands the gynecologic cancer experience. Join us!
OCRA’s International Gynecologic Cancer Conference is the largest and longest running conference focused on ovarian cancer, now with expanded sessions for those affected by gynecologic cancers. The conference brings together patients, caregivers, survivors, advocates and friends to learn about the latest developments in research, diagnosis, treatment and quality of life. All members of the gynecologic cancer community are welcome. Opportunities are also available for sponsorship.
Yes, this is the same annual conference. We have updated the conference name to reflect all the sessions, support and resources offered for those facing ovarian cancer, as well as the broader gynecologic cancer community.
OCRA’s conference is held online, so anyone from anywhere can join.
OCRA’s International Gynecologic Cancer Conference is free for all attendees.
If you registered for the Conference, you can continue to log in to watch sessions. Videos will be posted on OCRA’s website in the coming weeks.
Please view our sponsorship prospectus to discover opportunities for your company/organization to support the International Conference. For questions or more information on sponsorship opportunities, please contact elizabeth@meetingexpert.org.
We are happy to answer any questions you have. Just email conference@ocrahope.org or call (212) 268-1002 and our conference team will assist you.
OCRA’s International Gynecologic Cancer Conference would not be possible without the generous support of our sponsors. Interested in sponsoring OCRA’s International Conference? View sponsorship details or contact elizabeth@meetingexpert.org.
OCRA’s International Gynecologic Cancer Conference is the largest and most trusted conference devoted to the ovarian and gynecologic cancer community. It is the epicenter for researchers, clinicians, survivors, and friends to come together and learn from one another about developments in diagnosis, treatment, and quality of life for women with ovarian or gynecologic cancer.
Through your sponsorship, you play a key role in alerting women to the risk factors of ovarian cancer, helping researchers learn how better to screen and treat the disease, and giving power to ovarian cancer survivors’ voices. Together, we can work to bring awareness to ovarian cancer, increase the number of survivors in this country, and ultimately save more lives.
View Sponsorship Opportunities
Questions about Sponsorship?
Please contact Elizabeth White at elizabeth@meetingexpert.org.
For more information or questions about OCRA’s International Gynecologic Cancer Conference, please email us at conference@ocrahope.org.
For more information about sponsoring, please contact Elizabeth White at elizabeth@meetingexpert.org.
For press inquiries, please contact Amanita Duga-Carroll, ADC Strategic Communications, Inc., at adcstrategiccomms@gmail.com or (917) 597-7880.
Videos from OCRA’s 2025 conference are available to watch online. View the full suite of videos on OCRA’s YouTube channel.
September is Ovarian and Gynecologic Cancer Awareness Month—a time for our community to unite, raise awareness, and push forward in the search for better treatments and cures. This year, that push forward took a major step. In May, we launched the Research Exchange, a new kind of online community that represents a fundamental shift in how … Continued
Written by Julia Thayer, OCRA’s Associate Director, Advocacy Federal Rulemaking Update: Proposed Update to Uniform Guidance Advocacy isn’t limited to legislation and federal funding. This month, OCRA submitted a public comment on a proposed federal rule that could significantly impact how biomedical research is funded and conducted. On May 29, 2026, the Office of Management … Continued
Submit Your Questions for the FDA Listening Session On September 16–17, Ovarian Cancer Research Alliance (OCRA) will host the International Gynecologic Cancer Conference®, the largest conference dedicated to the gynecologic cancer community. Day 2 features a special opportunity: a Listening Session with leaders from the U.S. Food and Drug Administration (FDA). Ask questions about the FDA’s … Continued
Get email updates about research news, action alerts, and ways to join the fight.
Our website uses cookies to ensure you get the best experience. By continuing to use this website, you indicate that you have read and agree to our Terms of Use and Privacy Policy.
